Jaguar Health (JAGX) Total Debt (2014 - 2026)
Jaguar Health's (JAGX) quarterly Total Debt came in at $11.1 million in Q1 2026, down 39.9% year-on-year from $18.4 million in Q1 2025, and down 26.57% on a QoQ basis from $15.1 million in Q4 2025.
Jaguar Health (JAGX) Total Debt (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Total Debt data on file, last reported at $11.1 million in Q1 2026.
- On a quarterly basis, Total Debt fell 39.9% year-over-year to $11.1 million in Q1 2026; TTM through Mar 2026 was $11.1 million, a 39.9% decrease from a year earlier, with the FY2025 full-year figure at $15.1 million, down 35.83% from the prior year.
- Total Debt for Q1 2026 stood at $11.1 million, down from $15.1 million in the prior quarter.
- Over the last five years, Total Debt for JAGX reached as high as $31.2 million in Q3 2023 and fell as low as $7.6 million in Q3 2025.
- Historically, Total Debt has averaged $19.7 million across 5 years, with a median of $20.0 million in 2022.
- Across the five-year window, Total Debt jumped 74.67% in 2023 and sank 64.69% in 2025, its largest moves.
- Year by year, Total Debt stood at $17.7 million in 2022, then soared by 74.67% to $31.0 million in 2023, then dropped by 24.17% to $23.5 million in 2024, then plunged by 35.83% to $15.1 million in 2025, then decreased by 26.57% to $11.1 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $11.1 million in Q1 2026, $15.1 million in Q4 2025, and $7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | 108.47 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 959.06 Mn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 1.99 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 11.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.08 Mn |
| Dec 31, 2025 | 15.08 Mn |
| Sep 30, 2025 | 7.65 Mn |
| Jun 30, 2025 | 10.74 Mn |
| Mar 31, 2025 | 18.43 Mn |
| Dec 31, 2024 | 23.50 Mn |
| Sep 30, 2024 | 21.66 Mn |
| Jun 30, 2024 | 21.81 Mn |
| Mar 31, 2024 | 21.72 Mn |
| Dec 31, 2023 | 30.99 Mn |
| Sep 30, 2023 | 31.16 Mn |
| Jun 30, 2023 | 16.85 Mn |
| Mar 31, 2023 | 17.54 Mn |
| Dec 31, 2022 | 17.74 Mn |
| Sep 30, 2022 | 20.01 Mn |
| Jun 30, 2022 | 23.36 Mn |
| Mar 31, 2022 | 24.78 Mn |
| Dec 31, 2021 | 25.02 Mn |
| Sep 30, 2021 | 24.93 Mn |
| Jun 30, 2021 | 24.20 Mn |